Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease

Pediatric and Developmental Pathology

Volumn 13, Issue 1, 2010, Pages 24-31

  Furr, Anna E ^a,b   Ranganathan, Sarangarajan ^a   Finn, Olivera J ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory bowel disease; MUC1

Indexed keywords

MUCIN 1; PROTEIN ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; BIOPSY; CHILD; COLON; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATORY BOWEL DISEASES; MUCIN-1;

EID: 77949676160     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-06-0479.1     Document Type: Article

References (18)

1. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999;28:445-458.
2. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001; 120:622-635.
3. Rhodes JM, Campbell BJ, Finnie IA. Mucus and gastrointestinal tract. In: Pounder R, ed. Recent Advances in Gastroenterology, 10. Edinburgh: Churchill Livingstone, 1994;57-79.
4. Rhodes J, Yu L-G. Glycosylation and Disease. Encyclopedia of Life Sciences. Chichester, John Wiley & Sons, Ltd., July 2003.
5. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995;57:607-634.
6. Vlad AM, Kettel JC, Alajez NM, Carlos CA, Finn OJ. MUC1 immunobiology: from discovery to clinical applications. Adv Immunol 2004;82:249-293.
7. Longman RJ, Poulsom R, Corfield AP, Warren BF, Wright NA, Thomas MG. Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem 2006;54:1335-1348.
8. Hayashi T, Ishida T, Motoya S, et al. Mucins and immune reactions to mucins in ulcerative colitis. Digestion 2001;63 Suppl 1:28-31.
9. Hinoda Y, Nakagawa N, Nakamura H, et al. Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol Lett 1993;35:163-168.
10. Price MR, Rye PD, Petrakou E, et al. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol 1998;19 Suppl 1:1.
11. Raouf AH, Tsai HH, Parker N, Hoffman J, Walker RJ, Rhodes JM. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) 1992;83:623-626.
12. Parker N, Tsai HH, Ryder SD, Raouf AH, Rhodes JM. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 1995;56:52-56.
13. Clamp JR, Fraser G, Read AE. Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons. Clin Sci (Lond) 1981;61:229-234.
14. Rhodes JM. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar. Lancet 1996;347:40-44.
15. Beatty PL, Plevy S, Sepulveda A, Finn OJ. Cutting edge: transgenic expression of human MUC1 in IL102/2 mice accelerates inflammatory bowel disease and progression to colon cancer. J Immunol 2007;179:735-739.
16. Regimbald LH, Pilarski LM, Longenecker BM, Reddish MA, Zimmermann G, Hugh JC. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 1996;56:4244-4249.
17. Ren J, Agata N, Chen D, et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 2004;5:163-175.
18. Carlos CA, Dong HF, Howard OM, Oppenheim JJ, Hanisch FG, Finn OJ. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol 2005;175:1628-1635.